publication . Article . Other literature type . 2018

Chromatin remodelling and epigenetic state regulation by non-coding RNAs in the diseased heart

F. De Majo; Martina Calore;
Open Access
  • Published: 01 Mar 2018 Journal: Non-coding RNA Research, volume 3, pages 20-28 (issn: 2468-0540, Copyright policy)
  • Publisher: Elsevier BV
Epigenetics refers to all the changes in phenotype and gene expression which are not due to alterations in the DNA sequence. These mechanisms have a pivotal role not only in the development but also in the maintenance during adulthood of a physiological phenotype of the heart. Because of the crucial role of epigenetic modifications, their alteration can lead to the arise of pathological conditions. Heart failure affects an estimated 23 million people worldwide and leads to substantial numbers of hospitalizations and health care costs: ischemic heart disease, hypertension, rheumatic fever and other valve diseases, cardiomyopathy, cardiopulmonary disease, congenit...
Persistent Identifiers
free text keywords: Article, Cardiomyopathy, medicine.disease, medicine, Heart disease, Heart failure, Epigenetics, Bioinformatics, business.industry, business, Cardiopulmonary disease, Disease, Chromatin, Rheumatic fever, lcsh:Genetics, lcsh:QH426-470
Related Organizations
Funded by
MicroRNAs as therapeutic targets for ARVC.
  • Funder: European Commission (EC)
  • Project Code: 660440
  • Funding stream: H2020 | MSCA-IF-EF-ST
93 references, page 1 of 7

[1] G. Felsenfeld, A brief history of epigenetics, Cold Spring Harbor Perspect. Biol. 6 (1) (2014). [OpenAIRE]

[2] S.I.S. Grewal, D. Moazed, Heterochromatin and Epigenetic Control of gene expression, Science 301 (5634) (2003) 798e802. [OpenAIRE]

[3] S.R. Martinez, M.S. Gay, L. Zhang, Epigenetic mechanisms in heart development and disease, Drug Discov. Today 20 (7) (2015) 799e811.

[4] T. Thum, G. Condorelli, Long noncoding RNAs and microRNAs in cardiovascular pathophysiology, Circ. Res. 116 (4) (2015) 751e762.

[5] S. Khatibzadeh, F. Farzadfar, J. Oliver, M. Ezzati, A. Moran, Worldwide risk factors for heart failure: a systematic review and pooled analysis, Int. J. Cardiol. 168 (2) (2013) 1186e1194.

[6] R. Gilsbach, S. Preissl, B.A. Gruning, T. Schnick, L. Burger, V. Benes, et al., Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease, Nat. Commun. 5 (2014) 5288. [OpenAIRE]

[7] J.K. Takeuchi, X. Lou, J.M. Alexander, H. Sugizaki, P. Delgado-Olguin, A.K. Holloway, et al., Chromatin remodelling complex dosage modulates transcription factor function in heart development, Nat. Commun. 2 (2011) 187.

[8] C.P. Chang, B.G. Bruneau, Epigenetics and cardiovascular development, Annu. Rev. Physiol. 74 (2012) 41e68.

[9] C.T. Hang, J. Yang, P. Han, H.L. Cheng, C. Shang, E. Ashley, et al., Chromatin regulation by Brg1 underlies heart muscle development and disease, Nature 466 (7302) (2010) 62e67. [OpenAIRE]

[10] C. Schiano, M.T. Vietri, V. Grimaldi, A. Picascia, M.R. De Pascale, C. Napoli, Epigenetic-related therapeutic challenges in cardiovascular disease, Trends Pharmacol. Sci. 36 (4) (2015) 226e235.

[11] A. Berezin, Epigenetics in heart failure phenotypes, BBA clinical 6 (2016) 31e37. [OpenAIRE]

[12] P.A. Jones, D. Takai, The role of DNA methylation in mammalian epigenetics, Science 293 (5532) (2001) 1068e1070.

[13] D.E. Handy, R. Castro, J. Loscalzo, Epigenetic modifications: basic mechanisms and role in cardiovascular disease, Circulation 123 (19) (2011) 2145e2156.

[14] G. Auclair, M. Weber, Mechanisms of DNA methylation and demethylation in mammals, Biochimie 94 (11) (2012) 2202e2211.

[15] S. Guibert, M. Weber, Functions of DNA methylation and hydroxymethylation in mammalian development, Curr. Top. Dev. Biol. 104 (2013) 47e83. [OpenAIRE]

93 references, page 1 of 7
Any information missing or wrong?Report an Issue